Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+2.9%
5Y CAGR+12.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+2.9%/yr
vs +16.0%/yr prior
5Y CAGR
+12.9%/yr
Recent deceleration
Acceleration
-13.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $170.18M | +12.2% |
| 2024 | $151.61M | +5.1% |
| 2023 | $144.30M | -7.6% |
| 2022 | $156.10M | +23.5% |
| 2021 | $126.35M | +36.4% |
| 2020 | $92.64M | +22.6% |
| 2019 | $75.55M | -12.5% |
| 2018 | $86.34M | +31.6% |
| 2017 | $65.59M | -9.3% |
| 2016 | $72.35M | - |